1. As I navigate through the complexities of miRNA expression analysis using qPCR, my study involves a panel of 20 plates, each containing 96 wells—18 dedicated to patient samples and 2 for controls.
In categorizing my samples into newly diagnosed lymphoma/leukemia, those in remission, and those exhibiting resistance to treatment, I aim to calculate essential parameters such as ΔCT, ΔΔCT, and fold change. Is it appropriate to determine the average CT values for each subgroup to obtain a representative measure of miRNA expression within these distinct clinical states? keep in mind each group contain 3 samples from different individuals. Also is't acceptable to take multiple reference genes and take average of them for normalization?
Additionally, I encounter undetermined CT values; what would be the most judicious approach to handle these values? Should I assign them as 35?
Similarly, CT values exceeding 35 pose a challenge. How can I establish thresholds for further analysis in order to maintain data accuracy? because I cant delete any thing from genes as they are panel of miRNA
Moving into the statistical analysis phase, which methods, like ANOVA or t-tests, would be most effective in discerning significant differences between the categories of my samples?
Finally, in presenting my findings, how can I ensure clarity and transparency, incorporating well-organized tables and figures to visually convey the intricate dynamics of miRNA expression?
Moreover, how should I adeptly discuss the biological implications of my results while addressing potential limitations in my study?"
It's worth noting that the source of my samples is plasma, and they are derived from patients with hematological malignancies at various stages of the disease. Furthermore, each sample has been processed only once without any technical repeats.